Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101,439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial.
Qu J, Yu Z, Li Q, Chen Y, Xiang D, Tan L, Lei C, Bai W, Li H, Shang Q, Chen L, Hu X, Lu W, Li Z, Chen D, Wang X, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Chen G, Li Y, Zeng Z, Rong G, Dong Z, Chen Y, Lou M, Wang C, Lu Y, Zhang C, Yang Y. Qu J, et al. Among authors: yang y. Trials. 2014 Nov 10;15:438. doi: 10.1186/1745-6215-15-438. Trials. 2014. PMID: 25381721 Free PMC article. Clinical Trial.
A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B.
Chen Y, Wang Y, Chen Y, Yu Z, Chi X, Hu KQ, Li Q, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chi W, Dong Z, Wang X, Li Z, Xiao H, Chen D, Bai W, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Sun H, Deng M, Qi X, Zhang Z, Qi X, Yang Y. Chen Y, et al. Among authors: yang y. Clin Transl Gastroenterol. 2019 May 22;10(5):1-12. doi: 10.14309/ctg.0000000000000033. Clin Transl Gastroenterol. 2019. PMID: 31033506 Free PMC article.
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Rong G, Chen Y, Yu Z, Li Q, Bi J, Tan L, Xiang D, Shang Q, Lei C, Chen L, Hu X, Wang J, Liu H, Lu W, Chen Y, Dong Z, Bai W, Yoshida EM, Mendez-Sanchez N, Hu KQ, Qi X, Yang Y. Rong G, et al. Among authors: yang y. J Infect Dis. 2022 Mar 15;225(6):1091-1099. doi: 10.1093/infdis/jiaa266. J Infect Dis. 2022. PMID: 32437567 Free PMC article. Clinical Trial.
Implications of BMP9/10 for patients with liver cirrhosis.
Ji D, Chen G, Yang Y. Ji D, et al. Among authors: yang y. EBioMedicine. 2020 Jul;57:102859. doi: 10.1016/j.ebiom.2020.102859. Epub 2020 Jul 3. EBioMedicine. 2020. PMID: 32629390 Free PMC article. No abstract available.
Unreliable Estimation of Fibrosis Regression During Treatment by Liver Stiffness Measurement in Patients With Chronic Hepatitis B.
Ji D, Chen Y, Shang Q, Liu H, Tan L, Wang J, Chen Y, Li Q, Long Q, Song L, Jiang L, Xiao G, Yu Z, Chen L, Hu X, Wang X, Chen D, Li Z, Dong Z, Chen G, Yang Y. Ji D, et al. Among authors: yang y. Am J Gastroenterol. 2021 Aug 1;116(8):1676-1685. doi: 10.14309/ajg.0000000000001239. Am J Gastroenterol. 2021. PMID: 33840727 Free PMC article.
A novel nomogram to predict evident histological liver injury in patients with HBeAg-positive chronic hepatitis B virus infection.
Chang X, Wang J, Chen Y, Long Q, Song L, Li Q, Liu H, Shang Q, Yu Z, Jiang L, Xiao G, Li L, Chen L, Wang X, Li Z, Chen D, Dong Z, An L, Tan L, Chen Y, Yang Y. Chang X, et al. Among authors: yang y. EBioMedicine. 2021 May;67:103389. doi: 10.1016/j.ebiom.2021.103389. Epub 2021 May 17. EBioMedicine. 2021. PMID: 34004423 Free PMC article.
Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment.
Chang XJ, Shi YW, Wang J, Liu HB, Chen Y, Zhu XN, Chen YP, Yu ZJ, Shang QH, Tan L, Li Q, Jiang L, Xiao GM, Chen L, Lu W, Hu XY, Long QH, An LJ, Zou ZY, Wong VW, Yang YP, Fan JG. Chang XJ, et al. Among authors: yang yp. Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):416-425. doi: 10.1016/j.hbpd.2021.06.009. Epub 2021 Jul 7. Hepatobiliary Pancreat Dis Int. 2021. PMID: 34275749
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
Ji D, Chen Y, Bi J, Shang Q, Liu H, Wang JB, Tan L, Wang J, Chen Y, Li Q, Long Q, Song L, Jiang L, Xiao G, Yu Z, Chen L, Wang X, Chen D, Li Z, Dong Z, Yang Y. Ji D, et al. Among authors: yang y. J Hepatol. 2022 Dec;77(6):1515-1524. doi: 10.1016/j.jhep.2022.07.018. Epub 2022 Aug 18. J Hepatol. 2022. PMID: 35985545 Free article. Clinical Trial.
Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y, Ma X, Zhang X, Luo J, An L, Zhang Y, Chang X, Dong Z, Zhang W, Kong H, Zhao J, Ding H, Liu F, Yang Y. Chen Y, et al. Among authors: yang y. Hepatol Int. 2022 Dec;16(6):1379-1389. doi: 10.1007/s12072-022-10388-7. Epub 2022 Oct 18. Hepatol Int. 2022. PMID: 36255564 Clinical Trial.
101,439 results
You have reached the last available page of results. Please see the User Guide for more information.